Virtuix sells first enterprise system to Tesla for Optimus robots

Tesla purchased Virtuix's first Omni One Enterprise system for its Optimus humanoid robot division, pushing the simulation platform into industrial robotics.

Virtuix Holdings sold its first Omni One Enterprise system to Tesla for the automaker's Optimus humanoid robot division, extending the AI-driven simulation platform beyond consumer and defense markets into industrial robotics.

"We're pleased to see Omni One continuing to expand into enterprise applications," Jan Goetgeluk, founder and chief executive officer of Virtuix, said. "As organizations increasingly adopt immersive technologies for training and simulation, we believe our platform is demonstrating its versatility well beyond its original consumer market."

The Omni One Enterprise system uses an omni-directional treadmill — a moving platform that lets a person walk or run in any direction while staying in one place — to enable real-time teleoperation of humanoid robots. The purchase follows a series of milestones this year, including a collaboration with Meta to bring Omni One to Quest's 20 million-plus headset base, a selection by NASA for its year-long Moon and Mars mission analog, and partnerships with all four major branches of the US military.

The Tesla deal strengthens Virtuix's strategy of deploying its platform across multiple high-growth verticals. The company, which can produce as many as 3,000 units a month — representing an estimated $100 million in annual revenue potential — is scheduled to report fiscal first-quarter 2027 results on Aug. 13. Virtuix shares rose 3.5% on the news.

The Omni One Enterprise system's ability to support humanoid robot teleoperation places Virtuix at the intersection of two fast-growing markets: immersive simulation and robotics. Tesla's Optimus program, which aims to deploy humanoid robots for manufacturing and logistics tasks, requires training environments where operators can control robots remotely in real time — a use case Virtuix's platform directly addresses. The system allows a human operator to walk, turn, and crouch naturally within a compact physical footprint while those movements are replicated by a robot in a different location, effectively turning the operator into the robot's real-time controller.

The sale extends a run of commercial momentum for Virtuix that has accelerated through 2026. In July alone, the company won the Auggie Award for Best Interaction Product, was selected by NASA for its Mars surface analog mission, and signed a strategic partnership with Sirica Therapeutics to deploy systems for autism treatment. The Meta collaboration, announced earlier this month, gave Virtuix access to an installed base of more than 20 million Quest headsets and roughly 6 million active monthly users — a distribution channel that could convert casual VR users into paying Omni One customers.

Still, the stock has been volatile despite the positive news flow. Virtuix shares fell 17.9% after the Auggie Award win and 6.4% after the Sirica partnership, though they gained 7.1% on the earnings call notice and 3.5% on the Tesla announcement. Insider activity showed net selling during the reviewed period, adding a governance consideration for investors tracking the stock's direction.

For Tesla, the purchase is a small bet on simulation tools for its robotics division — negligible relative to the automaker's roughly $100 billion in annual revenue. But for Virtuix, landing Tesla as a customer provides a marquee reference account that could drive broader adoption among industrial and robotics companies evaluating similar training and teleoperation workflows. The company's ability to scale production to 3,000 units monthly suggests it is preparing for institutional demand beyond the consumer market where it started. With the Aug. 13 earnings call approaching, investors will be watching for any update on enterprise pipeline development and whether additional robotics customers follow Tesla's lead.

This article is for informational purposes only and does not constitute investment advice.